Errors in medication history at hospital admission: prevalence and predicting factors by Hellström, Lina M et al.
RESEARCH ARTICLE Open Access
Errors in medication history at hospital admission:
prevalence and predicting factors
Lina M Hellström
1*, Åsa Bondesson
2, Peter Höglund
3 and Tommy Eriksson
3
Abstract
Background: An accurate medication list at hospital admission is essential for the evaluation and further treatment
of patients. The objective of this study was to describe the frequency, type and predictors of errors in medication
history, and to evaluate the extent to which standard care corrects these errors.
Methods: A descriptive study was carried out in two medical wards in a Swedish hospital using Lund Integrated
Medicines Management (LIMM)-based medication reconciliation. A clinical pharmacist identified each patient’s
most accurate pre-admission medication list by conducting a medication reconciliation process shortly after
admission. This list was then compared with the patient’s medication list in the hospital medical records. Addition
or withdrawal of a drug or changes to the dose or dosage form in the hospital medication list were considered
medication discrepancies. Medication discrepancies for which no clinical reason could be identified (unintentional
changes) were considered medication history errors.
Results: The final study population comprised 670 of 818 eligible patients. At least one medication history error
was identified by pharmacists conducting medication reconciliations for 313 of these patients (47%; 95% CI 43-
51%). The most common medication error was an omitted drug, followed by a wrong dose. Multivariate logistic
regression analysis showed that a higher number of drugs at admission (odds ratio [OR] per 1 drug increase =
1.10; 95% CI 1.06-1.14; p < 0.0001) and the patient living in their own home without any care services (OR = 1.58;
95% CI 1.02-2.45; p = 0.042) were predictors for medication history errors at admission. The results further indicated
that standard care by non-pharmacist ward staff had partly corrected the errors in affected patients by four days
after admission, but a considerable proportion of the errors made in the initial medication history at admission
remained undetected by standard care (OR for medication errors detected by pharmacists’ medication
reconciliation carried out on days 4-11 compared to days 0-1 = 0.52; 95% CI 0.30-0.91; p=0.021).
Conclusions: Clinical pharmacists conducting LIMM-based medication reconciliations have a high potential for
correcting errors in medication history for all patients. In an older Swedish population, those prescribed many
drugs seem to benefit most from admission medication reconciliation.
Background
The problem of inaccurate medication lists at hospital
admission and discharge is extensive [1-3] and has
gained attention, specifically with regard to the issue of
patient safety, in recent years [1,4]. An accurate medica-
tion list at hospital admission is essential for the evalua-
tion and further treatment of patients, to prevent
medication errors and adverse drug events in hospital
and after discharge. Errors in the medication history are
sometimes identified and corrected early enough to pre-
vent any harm to the patient and are then of no clinical
importance, although the administrative work can waste
valuable time for the health care staff involved. Uniden-
tified errors, however, can result in the patient receiving
potentially harmful, inaccurate treatment. Possible
causes for the errors in medication histories are multi-
factorial, relating to the system, the patient, or the
health care staff [1,5-7].
Medication reconciliation has been endorsed by
patient safety organisations and authorities in a number
of countries as a method of improving the accuracy of
patients’ medication lists [1,4,8]. The Institute for
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described medication reconciliation as being “the pro-
cess of identifying the most accurate list of a patient’s
current medicines - including the name, dosage, fre-
quency, and route - and comparing them to the current
list in use, recognizing any discrepancies, and docu-
menting any changes, thus resulting in a complete list of
medications, accurately communicated” [1].
The Lund Integrated Medicines Management (LIMM)
model offers a systematic approach for individualising
and optimising drug treatment for inpatients [9]. The
LIMM model has been continuously developed and
implemented in a number of Swedish hospitals over
more than ten years. This model includes a pharmacist
intervention for medication reconciliation at admission,
team interventions for medication reviews and monitor-
ing during the hospital stay, and a discharge medication
reconciliation procedure. Previous studies have asso-
ciated the LIMM model with prescription of fewer inap-
propriate drugs [9,10] and reductions in the number of
drug-related patient revisits to hospital [9,11] and pri-
mary care [11]. A smaller early study also suggested that
using the LIMM medication reconciliation at admission
would effectively identify errors in the medication his-
tory [12]. It is also important to carry out a more com-
prehensive evaluation of the subsequent actions of the
pharmacists and medical practitioners. Evaluation of
these actions (e.g. suggestions for change and changes
made to the prescriptions) can provide insight into the
factors responsible for the identified outcomes and sug-
gestions for optimizing the intervention [13]. Further-
more, there is a need to determine whether it is possible
to identify patients with the greatest risk of experiencing
medication history errors at hospital admission. If those
patients can be identified in clinical practice, it will
enable better resource allocation, as interventions to
prevent medication history errors can be directed
towards the relevant groups. Results concerning which
risk factors predict such errors in medication histories
are currently contradictory [5-7,14-17].
The objective of this study was to describe the fre-
quency and type of medication history errors identified
by pharmacists performing medication reconciliations
for patients admitted to a Swedish hospital, and to eval-
uate predictors for those medication errors. A secondary
objective was to evaluate the degree to which standard
care identifies errors in the medication history when the
pharmacist’s medication reconciliation is delayed.
Methods
Setting and population
This prospective study was conducted in two internal
medicine wards (designated A and B) at the University
hospital of Lund, Sweden. A LIMM-based clinical
pharmacy service, including medication reconciliation at
admission, was implemented in January and October,
2007, in the respective wards. All patients admitted to
wards A and B after implementation of the service until
the end of the year 2007, were eligible for inclusion in
the study. Patients discharg e do rd e c e a s e db e f o r et h e
pharmacist could conduct admission medication recon-
ciliation were excluded from the study. There were 22
beds in each ward. The weekday staff in each ward com-
prised two junior physicians and two senior physicians,
one clinical pharmacist, three nurses, three assistant
nurses, one physiotherapist and one occupational thera-
pist. Availability of beds alone decided the ward to
which a patient was admitted. The wards used the stan-
dard hospital electronic health record (EHR) system
(Melior
®, Siemens Corp.); this was used in all hospital
wards but was not used in primary care. The primary
care centres in the region surrounding the hospital used
either another EHR system or paper-based health
records. Community care services used paper-based
medication lists. The different levels of care (i.e. pri-
mary, secondary and community care) exchanged infor-
mation about the patients’ current medication lists by
phone, fax, or mail. No electronic communications
between the hospital and the primary care centres or
community care services was possible at the time of the
study. The regional ethical board of the University of
Lund, Sweden, did not consider ethical approval to be
necessary and had no objections to the study.
Collection of data
A two-step procedure was used to collect and classify
data on medication discrepancies and errors in the med-
ication histories. Firstly, clinical pharmacists conducted
medication reconciliations and documented their work
in a LIMM medication interview questionnaire form
(Additional file 1). Five different pharmacists worked at
the wards during the study period. Secondly, two phar-
macy students and a research pharmacist classified the
identified discrepancies and errors.
The medication reconciliation process in the LIMM model
The admission medication reconciliation process in the
LIMM model is comprehensive and was developed over
about 5 years and implemented on top of standard care
[9,12]. Following a strict protocol, clinical pharmacists
identified the patient’s pre-admission medication list.
For patients capable of participation and willing to parti-
cipate, an initial medication interview was conducted.
The pharmacist asked which medications and dosages
the patient had been taking before admission. Specific
questions were asked about the use of painkillers, heart
medications, stomach medications, sleeping pills, anti-
diabetics, eye drops, inhalation drugs, over-the-counter
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ability of including all the patient’s medications. Some-
times, a medical interview was conducted with a close
relative instead of the patient. In addition (or otherwise,
if an interview could not be conducted), the pharmacist
consulted all available pre-admission lists, including
drug lists from primary and community care, the
national pharmacy register (all drugs dispensed within
the past 15 months) [18], and prescription forms from
the medication dispensing system ApoDos (a multi-dose
system where all medications that the patient should be
taking on one occasion are machine-packed together in
small, fully labelled plastic b a g sa tap h a r m a c yd i s p e n -
sing centre and delivered to the patient every second
week) [19]. Based on this information, a list with the
patient’s prescribed medications was documented in the
LIMM medication interview questionnaire, part 1 (Addi-
tional file 1). Parts 2 and 3 of the LIMM medication
interview questionnaire were conducted with some
patients; these parts comprised questions about knowl-
edge of, practical handling of, adherence with, and
beliefs about medications [9]. This paper reports the
results from part 1 only.
The pre-admission medication list identified by the
pharmacist was regarded as the most accurate list avail-
able since it was based on all available information
sources and had been compiled according to a well
established, systematic method [5,6,20-22]. Differences
between this pharmacist-compiled pre-admission medi-
cation list and the medication list in the hospital EHR
were documented in the LIMM medication interview
questionnaire. The pharmacist consulted the patient’s
EHR to establish possible reasons for the differences.
Discrepancies noted in the hospital medication list
which the pharmacist judged relevant and possibly
requiring correction were discussed with a ward physi-
cian. The pharmacist recommended corrections for the
hospital EHR, and the physician then made the final
decision and was responsible for correcting the hospital
EHR list when necessary. The use of over-the-counter
drugs and herbal drugs by the patients was also docu-
mented in the questionnaire and discussed with the
physician when considered clinically relevant. The phar-
macists’ recommendations and the subsequent actions
by the physician or pharmacist were documented in a
medication review form.
It was ward policy that a clinical pharmacist should
conduct the LIMM-based medication reconciliation
within one day of admission to the ward or on Mondays
for patients admitted on weekends. Medication reconci-
liation was conducted once for each patient and took on
average 32 minutes per patient if a patient interview was
conducted and 15 minutes if no interview was con-
ducted [unpublished observations, personal
communication Tommy Eriksson 27/03/2012]. This
time included the face-to-face discussion with a physi-
cian about discrepancies in the hospital medication list.
Occasionally, it took longer than one day for the phar-
macist to conduct the medication reconciliation. This
was attributed to time constraints, lack of personnel, or
temporarily closed wards because of an infection out-
break among the patients. If a clinical pharmacist was
not available, physicians and/or nurses occasionally cor-
rected errors in the medication history (standard care),
but there were no instructions or forms for these
changes, in contrast to the LIMM-based structured
medication reconciliations.
Definition and classification of medication discrepancies
and errors
The identified differences between the pharmacist-
acquired medication list and the medication list in the
EHR were classified retrospectively by reviewing the
LIMM medication interview questionnaires and the
EHR. A medication discrepancy was defined as an addi-
tion or withdrawal of a drug, or a change to the dose or
dosage form. An incorrect dosage interval was not
defined as a discrepancy if the total dosage/24 h had not
been changed. Changes to an equivalent generic drug or
withdrawal of drugs with a long dosage interval, e.g.
once monthly, were also not regarded as medication dis-
crepancies. The medication discrepancies were further
classified by type: drug omitted (the drug had not been
registered in the hospital EHR drug list), additional drug
(a drug had been erroneously added to the hospital EHR
drug list), dosage too high, dosage too low, or wrong
dosage form.
Medication discrepancies for which the reviewing
pharmacists could not identify any clinical reason (unin-
tentional changes) were deemed to be medication errors.
Our definition of a medication error was based on the
definition proposed by Leape [23]: “A medication error
is any error in the process of prescribing, dispensing or
administering a drug, whether there are adverse conse-
quences or not”. There were two exceptions to this: that
only errors in the medication history were included, and
that discrepancies corrected before reaching the patient
were not considered medication errors. For example,
discrepancies concerning weekly doses that were identi-
fied before the dosing occasion or involving omission of
drugs that were to be given as needed and which the
patient had not yet required were not counted as errors.
Over-the-counter drugs and herbal drugs were not
included in the drug list in the EHR and hence could
not result in medication discrepancies or errors.
Two pharmacy students (doing their Masters theses)
were responsible for the classification of medication dis-
crepancies and errors as described above. They were
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sification procedure and they continually discussed any
lack of clarity with the research pharmacist. To evaluate
the percent of cases which the raters agreed upon, 30
patients were classified independently by the two stu-
dents and one research pharmacist (LH). The agreement
with regard to the number and type of medication
errors was 83%.
Statistics
An open source software based on the R language and
environment for statistical computing (http://www.R-
project.org) was used for all statistical analyses [24].
Descriptive statistics are shown as medians (interquartile
range), means (95% confidence intervals, CI) and fre-
quencies or percentages (95% CI) when appropriate.
The denominator for calculating the error rate was the
number of prescribed medications in the hospital EHR
before medication reconciliation, plus any medications
omitted. A multivariable binary logistic regression analy-
sis was conducted where the response variable was the
presence or absence of medication errors. The following
model variables were pre-specified potential predictors:
number of drugs at admission (every increase by one
drug), age (every 10 years’ increase), sex (0 = Female, 1
= Male), type of care service before admission (0 = Liv-
ing in own home with no care service, 1 = Living in
own home but enrolled in community home care ser-
vices, 2 = Living in care home), and directly admitted to
the study ward without transferral from another ward (0
= No, 1 = Yes). In addition, the extent to which stan-
dard care identified medication errors was evaluated by
including the number of days from admission to the
ward until medication reconciliation (0 = 0-1 days, 1 =
2-3 days, 2 = 4 days or more) in the model. This vari-
able was not considered a potential predictor but was
included in order to evaluate if the medication errors
remained undetected by standard care if the LIMM
admission medication reconciliation was delayed. The
variables “2-3 days” and “4 days or more” were not tar-
geted controls; the medication reconciliation was
delayed because of time constraints or other factors and
never deliberately. No variables were eliminated from
the regression model. Eleven percent of the data for the
variable “directly admitted to the study ward”,a n d1 0 %
for “number of days from admission to the ward until
medication reconciliation” were missing. Data were
complete for the other variables. In the multivariable
regression model, missing data was imputed using a
multiple imputation method [25]. The le Cessie-van
Houwelingen-Copas-Hosmer unweighted sum of
squares test for global goodness of fit was used to assess
the fit of the model [25]. The significance level in the
analysis was set to 0.05.
Results
Description of the study sample
In total, 818 patients were eligible for inclusion. Patients
who did not receive a medication reconciliation (n =
137) and patients for whom important demographic and
study data were missing (n = 11) were excluded. The
final study population comprised 670 patients: 524 in
ward A and 146 in ward B. The characteristics of the
study population are summarised in Table 1. Most of
the patients (62%) were aged over 80 years and 66% had
been prescribed more than five drugs for regular use
before admission to hospital. Seven percent were
younger than 65 years. There were no differences in
patient characteristics between wards A and B.
Description of the medication reconciliation process
The clinical pharmacists identified 1136 medication dis-
crepancies between the lists for 420 of 670 patients
(63%; 95% CI 59 to 66%). The mean of medication dis-
crepancies in the total cohort was 1.7 (95% CI 1.6-1.8)
per patient, and the mean per affected patient was 2.7
(95% CI 2.5-2.9). The actions of the pharmacists and
physicians after the initial identification of discrepancies
are summarised in Figure 1. The pharmacists recom-
mended correction of 813 discrepancies (71%). For 567
of the 813 suggestions (70%), the medication list was
corrected accordingly by the physician. In 193 cases
(24%), it was unknown whether the medication list was
corrected after the pharmacist’s recommendation. Either
the discrepancy was no longer relevant for the patient,
or the pharmacist did not document the results because
of lack of time, or the physician never decided on an
eventual correction.
Frequency and types of errors in medication history
Of the 1136 identified medication discrepancies, 672
(59%) were classified as medication errors. These
errors affected 313 patients, representing a frequency
of 47% (95% CI 43 to 51%). The error rate was 10.2%
(672/6582) of the total number of prescribed drugs at
Table 1 Characteristics of the study participants (n = 670)
Age, mean, in years (SD) 81 (10)
Sex, % female 53%
Number of drugs at admission, median (IQR)
Regular use 7 (5-11)
As needed 1 (0-2)
Patients using a multi-dose system (ApoDos
®), % of patients 21%
Length of stay in the ward, median days (IQR) 8 (4-12)
Number of drugs at discharge, median (IQR)
Regular use 8 (5-11)
As needed 1 (1-3)
SD, standard deviation. IQR, interquartile range
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cohort) was 1.0 (95% CI 0.9-1.1) medication error per
patient, and the mean per affected patient was 2.1
(95% CI 1.9-2.3). Twenty-three percent of the patients
had one error, 11% had two errors and 13% had
between three to nine errors. The most common medi-
cation error was omission of a drug, followed by a
wrong dose. The frequencies of the various types of
medication error and the most commonly associated
drug classes are shown in Table 2. Overall, 93% (n =
627) of the medication errors resulted in correction of
the EHR medication lists, as a result of either the
pharmacist’s suggestion (n = 549) or the physician’s
initiative before the pharmacist’ss u g g e s t i o n( n=7 8 )
(Figure 1).
Predicting errors in medication history
In the multivariable logistic regression model, an
increased number of drugs at admission and absence of
any care service before hospital admission (i.e. patients
living in their own homes without community care ser-
vice) were significant predictors for medication errors
(Table 3). The odds for a patient experiencing at least
one medication error increased by 10% for every addi-
tional medication at admission (OR 1.10; 95% CI 1.06-
1.14). Among patients living in their own homes without
any care service, 48% experienced at least one error
compared to 47% of those living in a care home (OR
1.58; 95% CI 1.02-2.45). The remaining prediction fac-
tors included in the regression model showed no corre-
lation with the risk of experiencing medication errors.
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Figure 1 Illustration of the medication reconciliation process. The figure includes the number of identified medication discrepancies (MD),
the number of pharmacist-suggested changes, and the number of corrected drug prescriptions. The number of discrepancies that were later
classified as medication errors (ME) by the reviewing pharmacists is also given.
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care
As the variable for the number of days until medication
reconciliation was included in the regression model, it
can be assumed that the patients reconciled on days 4-
11 had the same adjusted rate of medication error when
they were admitted to hospital as the rest of the
patients. The odds ratio for medication errors detected
by pharmacist medication reconciliation was 0.52 (95%
CI 0.30-0.91) on days 4-11 (Table 3). The results thus
suggest that, in a statistically significant proportion of
the patients reconciled on days 4-11 who had medica-
tion errors at admission, the errors had already been
corrected at the time of pharmacist medication reconci-
liation and that standard care was responsible for these
corrections. In the remaining patients who had
medication errors in their EHRs at admission, the errors
were still undetected by standard care after 4-11 days
and instead identified by the pharmacist medication
reconciliation. Within 2-3 days after admission, the
probability that a pharmacist would detect the errors
was as high as that on days 0-1 (Table 3), i.e. standard
care did not correct significantly more errors when the
pharmacist’s medication reconciliation was moderately
delayed.
Discussion
In our study population of mainly older patients,
approximately 50% were affected by errors in the medi-
cation history at admission to hospital. The most com-
mon error was the erroneous omission of a drug from
the hospital EHR medication list. Predictors of the
Table 2 Number of medication errors by type, and most frequent ATC codes for each type of error.
Type of error Medication errors; numbers (%) The three most frequent ATC codes by type of error; number of errors
B03 C07 N02 N05 N06 R03
Omission of drug 417 (62) 37 37 47
Dose too high 86 (13) 8 9 11
Dose too low 82 (12) 11 12 7
Additional drug 79 (12) 7 8 8
Wrong dosage form 8 (1) 3 3 2
Total 672 (100) 67 68 57
ATC-codes: B03, Antianemic preparations; C07, Beta-blocking agents; N02, Analgesics; N05, Psycholeptics; N06, Psychoanaleptics; R03, Drugs for obstructive
pulmonary disease
ATC, Anatomic Therapeutic Chemical
Table 3 Predictors of errors in the medication history at admission to hospital.
Potential predictors Number of patients with an
error (%)
Odds ratio (95%
CI)
Number of drugs at admission For each 1-drug increase 313 (47) 1.10 (1.06-1.14)*
Age For each 10-yr increase 313 (47) 1.08 (0.92-1.27)
Ward A 250 (48) Reference
B 63 (43) 0.82 (0.56-1.21)
Sex Male 135 (43) Reference
Female 178 (50) 1.33 (0.96-1.83)
Type of care service before admission Care home 63 (47) Reference
Own home with community care
services
74 (45) 1.08 (0.67-1.75)
Own home, no care service 176 (48) 1.58 (1.02-2.45)*
Directly admitted to study ward
a Yes 155 (47) Reference
No; transferred from another ward 131 (49) 1.12 (0.80-1.57)
Days until medication reconciliation
Number of days until the pharmacist’s medication
reconciliation
a
0-1 days 168 (51) Reference
2-3 days 101 (49) 0.85 (0.59-1.23)
4-11 days 24 (38) 0.52 (0.30-0.91)*
Odds ratios were derived from a multivariable binary logistic regression model
* p < 0.05
aNumber (%) of patients is reported only for those with complete data. In the logistic regression model missing data was imputed
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number of preadmission drugs and living in one’so w n
home without community care service.
Our findings are similar to those of other studies
[2,17,20], but there are also reports of lower [15] or
higher [2,6] rates of error in medication histories at hos-
pital admission. Different definitions of medication dis-
crepancies and errors and variability in methods of data
collection could explain the differences between studies
and make it difficult to compare rates of error across
studies.
The association between the number of prescribed
drugs at admission and the occurrence of medication
errors was not surprising. Previously, some researchers
have found associations between errors in the medica-
tion history and the number of drugs at admission
[5,14], but some have not [6,15,16]. To the best of our
knowledge, the association between absence of any care
service before admission and medication errors has not
been previously suggested. It is likely that the type of
care service is not, in itself, important. Rather, the avail-
ability of a current medication list at hospital admission
might be the important underlying factor. Patients in
community care or care homes often take a current
medication list with them to hospital, possibly facilitat-
ing the recording of the initial medication history by a
physician or nurse and subsequently lowering the risk
for medication errors. However, the absolute difference
between the groups (48% vs 47% of patients with an
error, as seen in Table 3) was small and the value of
this predictor in clinical practice would be limited. Also,
the influence of this predictor is likely to vary substan-
tially between settings and above all between countries;
it will depend on the level of communication between
community care services and the hospital, and on the
routines for the patient taking their medication lists or
medications with them when attending the emergency
department.
There are varying results from other research on pre-
dictors for errors in the medication history. In accor-
dance with our results, Gleason and colleagues found
that there were few predictors associated with medica-
tion errors at admission and they suggested that well-
designed processes for medication history verification
were more important than patient characteristics [5]. In
contrast to our results, some researchers have found
that higher age [5,14,15] is a significant predictor. How-
ever, the patients in our study wards were older than
those in previous studies [5,14,15], and our results
might have differed if the patient cohort had been
younger. Previous studies have identified significant pre-
dictors for errors in the medication history which were
not included in our regression model, e.g. certain “high-
risk” drugs, many outpatient visits during the previous
year, and staffing levels [6,7].
The relative importance of the medication reconcilia-
tion by a pharmacist in terms of added value compared
to standard care was also of interest. Optimally, this
should be studied in a randomized, controlled trial.
Because we were unable to carry out a randomized trial,
we used an indirect measure to evaluate the degree to
which standard care corrected medication errors. The
pharmacists did not conduct the medication reconcilia-
tion until 4-11 days after admission for 20% of the
patients due to time constraints or lack of personnel. If
standard care had not identified and corrected any med-
ication errors at all, the probability that the pharmacists
identified medication errors on days 4-11 would have
been as high as that on days 0-1. However, regression
analysis suggested that the probability that there would
still be an error in a patient’s medication history after 4
or more days in the ward was lower compared to days
0-1. This implies that standard care had had partly cor-
rected the errors in affected patients by that time, but a
considerable proportion of the errors made in the initial
EHR medication history at admission remained unde-
tected by standard care. Two to three days after admis-
sion, the probability that patients would still be
prescribed the wrong drug or dose was as high as the
first day after admission. The potentially severe nature
of some of the errors in medication history [5,17,21]
underlines the importance of reconciling the medication
list soon after admission to avoid patient harm as a con-
sequence of error, preferably within 24 hours of
admission.
We believe it is necessary for medication reconcilia-
tion processes to be well designed and systematic, and
aided by structured forms and detailed guidelines. Clini-
cal pharmacists, as key members of a multidisciplinary
team, are very well suited to perform such systematic
medication reconciliations. A review by the British
National Institute for Health and Clinical Excellence [1]
showed that there is evidence that pharmacist interven-
tions are the most effective among the studied medica-
tion reconciliation interventions. However, it was
commented that the current evidence is poor and
further comparative studies of different medication
reconciliation programs will be needed to reveal which
approach is most effective from a clinical and economic
perspective. There are many promising and emerging
technologies that may be effective in medicines reconci-
liation as well. Nonetheless, our results highlight the
benefits of structured reconciliations by pharmacists
over occasional reconciliations as part of standard care.
The physicians’ acceptance of the pharmacists’ recom-
mended changes to drug therapy is often used in studies
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this study, 94% of the recommendations from the phar-
macist concerning errors in medication history were
accepted and implemented by the physicians, which sug-
gests that the process was effective. In a number of
cases, there was no information about the measures
taken by the physicians after the pharmacists’ recom-
mendations, or about the pharmacists’ reasons for not
recommending changes to the medication list. More
precise documentation might have provided even better
insight into the effectiveness of the process.
T h i ss t u d ya d d st ot h ee v i d e n c et h a tL I M M - b a s e d
patient care in hospital offers a positive contribution.
We detected and corrected medication errors in almost
half of the study patients. Although this study did not
evaluate possible harm from these errors, a study
including a sample of our study patients reported the
clinical significance of pharmacists’ recommendations
[26]. Recommendations were ranked by two physicians
on a six-point scale from 1 (adverse significance) to 6
(extremely significant). Of 70 recommendations, 59%
were ranked somewhat significant, 23% significant and
10% very significant. Seven percent had no significance
and one recommendation was judged to have adverse
significance. However, this case did not result in docu-
mented patient harm. Fifty-six of our study patients
were also followed up as part of an intervention study
[9]. That study showed that LIMM-based medication
reconciliation at admission and medication reviews in
hospital improve the appropriateness of drug therapy
and may also decrease drug-related revisits to hospital.
The results of the admission process (i.e. the correction
of medication errors) in the present study are therefore
very likely to be at least partly responsible for these
positive clinical outcomes [9].
This study had several limitations. Firstly, it was con-
ducted in an internal medicine population in a single
hospital, which limits the generalisability. Secondly,
acceptance of the pharmacist-acquired medication list as
the most accurate preadmission drug list available could
be questioned. It is possible that some medication dis-
crepancies escaped our detection. However, studies have
shown that pharmacists appear to be especially suited
and more effective than physicians when obtaining med-
ication histories [22] and the methods used by pharma-
cists to obtain medication histories are well established
[5,6,20,21]. Our method was strengthened by the fact
that the pharmacists used a number of different infor-
mation sources apart from the patient interview; for
example, pharmacy records are known to improve the
accuracy of medication lists [27]. The pharmacists were
also well informed of the requirements and followed a
strict protocol for the medication reconciliation process.
Thirdly, the classification of discrepancies into
medication errors partly relies on subjective judgment
and is therefore subject to bias.
Conclusions
We conclude that medication history errors at hospital
admission are common, which highlights the importance
of introducing processes for ensuring that the medication
lists are accurate and complete as soon as possible after
admission. Clinical pharmacists can be valuable in per-
forming structured medication reconciliations to reduce
the risk of medication errors. Our findings suggest that
there is limited potential for predicting which patients are
at highest risk of experiencing errors in their medication
history. More research is needed, particularly to uncover
the reasons for the possible impact of pre-admission care
services on medication errors. In general, we believe that
systematic medication reconciliations should be conducted
in all patients admitted to hospital. Among older patients
admitted to Swedish hospitals, those being prescribed
many drugs could benefit the most from admission medi-
cation reconciliations by clinical pharmacists.
Additional material
Additional file 1: LIMM Medication Interview Questionnaire. The
LIMM Medication Interview Questionnaire used by the clinical
pharmacists when conducting admission medication reconciliation.
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